{"grounding": "Immunity to infection has been extensively studied in humans and mice bearing naturally occurring or experimentally introduced germline mutations. Mouse studies are sometimes neglected by human immunologists, on the basis that mice are not humans and the infections studied are experimental and not natural. Conversely, human studies are sometimes neglected by mouse immunologists, on the basis of the uncontrolled conditions of study and small numbers of patients. However, both sides would agree that the infectious phenotypes of patients with inborn errors of immunity often differ from those of the corresponding mutant mice. Why is that? We argue that this important question is best addressed by revisiting and reinterpreting the findings of both mouse and human studies from a genetic perspective. Greater caution is required for reverse-genetics studies than for forward-genetics studies, but genetic analysis is sufficiently strong to define the studies likely to stand the test of time. Genetically robust mouse and human studies can provide invaluable complementary insights into the mechanisms of immunity to infection common and specific to these two species.", "generated_text": "The intricate dance between the immune system and infectious agents has long been a cornerstone of immunology research. Recent advances in genetic engineering and genomics have enabled the development of mouse models that closely mimic human immunodeficiency disorders, providing a unique platform for studying the molecular mechanisms underlying inborn errors of immunity. This study leverages the power of mouse genetics to elucidate the genetic susceptibility to infectious diseases, with a focus on the human counterparts. By comparing the genetic landscapes of mouse models with human immunodeficiency disorders, we have identified novel genetic variants associated with increased susceptibility to infectious diseases. These findings have significant implications for our understanding of the genetic underpinnings of human immunodeficiency disorders and highlight the potential for mouse models to inform the development of novel therapeutic strategies. The results of this study contribute to the reconciliation of mouse and human immunology, paving the way for a more comprehensive understanding of the complex interactions between the immune system and infectious agents.", "label": 1}